Inventor · disambiguated record
Jonathan Day
Also filed as: DAY JONATHAN · DAY JONATHAN W · DAY JONATHAN WESLEY
19 granted patents·10 pending applications·223 citations·filing 2002–2025
94Inventor score
Files withLILLY CO ELI12BIOMARIN PHARM INC3DIMARCHI RICHARD D2UNIV INDIANA RES & TECH CORP2BIANCHI ELISABETTA1
Top patents by PatentIndex Score
29 records- 0197US10709766B2Fusion proteinsLILLY CO ELI·Filed 2017·Granted Jul 14, 2020·19 cites·13 claims
- 0296US9855318B2Fusion proteinsLILLY CO ELI·Filed 2016·Granted Jan 2, 2018·23 cites·4 claims
- 0394US8450270B2Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffersDIMARCHI RICHARD D·Filed 2009·Granted May 28, 2013·37 cites·16 claims
- 0492US11253574B2Fusion proteins and methods of useLILLY CO ELI·Filed 2020·Granted Feb 22, 2022·2 cites·3 claims
- 0592US8546327B2Glucagon/GLP-1 receptor co-agonistsDIMARCHI RICHARD D·Filed 2009·Granted Oct 1, 2013·26 cites·20 claims
- 0691US12059452B2Fusion proteinsLILLY CO ELI·Filed 2022·Granted Aug 13, 2024·1 cites·5 claims
- 0791US8900593B2Glucagon/GLP-1 receptor co-agonistsUNIV INDIANA RES & TECH CORP·Filed 2013·Granted Dec 2, 2014·16 cites·8 claims
- 0891US8454971B2Glucagon/GLP-1 receptor co-agonistsDAY JONATHAN·Filed 2008·Granted Jun 4, 2013·31 cites·8 claims
- 0987US11242370B2Neuregulin-4 compounds and methods of useLILLY CO ELI·Filed 2020·Granted Feb 8, 2022·2 cites·8 claims
- 1087US2025032588A1Fusion proteinsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1186US8969294B2Glucagon/GLP-1 receptor co-agonistsBIANCHI ELISABETTA·Filed 2012·Granted Mar 3, 2015·14 cites·12 claims
- 1283US7115822B1Indirect entry cable gland assemblyJOY MM DELAWARE INC·Filed 2006·Granted Oct 3, 2006·33 cites·16 claims
- 1379US2025092107A1Neuregulin-4 compounds and methods of useLILLY CO ELI·Filed 2024·Application pending·0 cites
- 1473US12180270B2Anti-ANGPTL 3/8 complex antibodies and methods of using the sameLILLY CO ELI·Filed 2021·Granted Dec 31, 2024·0 cites·16 claims
- 1573US12145972B2Neuregulin-4 compounds and methods of useLILLY CO ELI·Filed 2021·Granted Nov 19, 2024·0 cites·29 claims
- 1670US11492395B2Polynucleotides for preparing ANGPTL 3/8 complexesLILLY CO ELI·Filed 2021·Granted Nov 8, 2022·0 cites·8 claims
- 1768USD586201STruck bed tool tie down anchorDAY JONATHAN W·Filed 2006·Granted Feb 10, 2009·19 cites·1 claims
- 1864US11242383B2Anti-ANGPTL ⅜ complex antibodies and methods of using the sameLILLY CO ELI·Filed 2019·Granted Feb 8, 2022·0 cites·33 claims
- 1964US10919959B2ANGPTL3/8 complexes and methods of using the sameLILLY CO ELI·Filed 2019·Granted Feb 16, 2021·0 cites·2 claims
- 2063US9447162B2Glucagon/GLP-1 receptor co-agonistsUNIV INDIANA RES & TECH CORP·Filed 2014·Granted Sep 20, 2016·0 cites·4 claims
- 2161US12233106B2C-type natriuretic peptide variants to treat skeletal dysplasia in childrenBIOMARIN PHARM INC·Filed 2022·Granted Feb 25, 2025·0 cites·14 claims
- 2261US2025057962A1Processable compositions and use for the sameRIPPLE THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 2359US2010050317A1Glove with anti-roll down/anti-rucking cuffREGENT MEDICAL LTD·Filed 2007·Application pending·0 cites
- 2452US2013139294A1Puncture And/Or Cut Resistant Glove Having Maximized Dexterity, Tactility, And ComfortZETUNE KATHLEEN·Filed 2011·Application pending·0 cites
- 2551US2025170217A1C-type natriuretic peptide variants to treat skeletal dysplasia in childrenBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
- 2651US2025032576A1CNP TherapyBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 2746US2004237208A1Leather productionFiled 2002·Application pending·0 cites
- 2843US2009255023A1Surgical and medical garments and materials incorporating shear thickening fluidsWILLIAMS T HAYDN·Filed 2007·Application pending·0 cites
- 2933US2022272415A1Demonstration of mobile device applicationsSALESFORCE COM INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →